Para-Clinical and Immunological Evaluation in Buerger's Disease as a Suspected Autoimmune Disease: Case Series

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 281

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RBMB-9-4_002

تاریخ نمایه سازی: 24 فروردین 1400

Abstract:

Background: Autoimmunity causes the loss of normal immune homeostasis and involves the presence of autoantibodies and inflammation. Thromboangiitis obliterans or Buergerchr('39')s disease (BD) refers to a type of vascular obstructive syndrome, with tobacco exposure accounting for disease formation and progression. However, the current understanding of autoimmunity is unclear in the context of BD, and the scientific findings are not enough to support autoimmune mechanisms. This study was aimed at investigating autoimmunity factors in patients with BD. Methods: Clinical and experimental examinations were performed on 80 patients with BD. The diagnostic work-up for autoimmunity was composed of IgM rheumatoid factor (RF), anti-nuclear antibodies (ANA), The erythrocyte sedimentation rate (ESR), anti-cyclic citrullinated peptide (CCP) antibodies, Antiphospholipid antibodies (APA), Anti-cardiolipin antibodies (ACLA), anti-double-stranded DNA (ds-DNA), and extractable nuclear antigen (ENA) profile. Immunomarkers were detected using the quantitative enzyme-linked immunosorbent assay (ELISA). Results: Raynaudchr('39')s phenomenon (84.93%), cold sensitivity (76.25%), and claudication (73.75%) were the most common symptoms in the BD patients. Also, 64.29% represented with high ANA levels and positive RF, while 42.11% were found with increased ANA and ESR levels. The ANA/RF positive BD patients had ESR> 15 mm/hr and a high prevalence of cold sensitivity, claudication, and Raynaudchr('39')s phenomenon (p> 0.05). Conclusions: There is a possibility of a non-specific autoimmune disposition among BD patients. RF and ANA could be considered for predicting disease progression.

Authors

Abbas Shapouri-Moghaddam

Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Seyed Jalil Tavakkol Afshari

Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Hamid reza Rahimi

Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Mohammad-Hadi Saeed Modaghegh

Vascular and Endovascular Surgery Research Center, Alavi Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

Mahmoud Mahmoudi

Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Seyed Morteza Ehteshamfar

Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Klein-Weigel P, Volz T, Gutsche-Petrak B, Boehnlein J, Bohlen A. ...
  • Narváez J, García-Gómez C, Álvarez L, Santo P, Aparicio M, ...
  • Rivera-Chavarría IJ, Brenes-Gutiérrez JD. Thromboangiitis obliterans (Buerger's disease). Ann Med ...
  • Jiménez-Ruiz C, Dale L, Mochales JA, Buendía LV, de Granda ...
  • Igari K, Inoue Y, Iwai T. The epidemiologic and clinical ...
  • Higashi Y, Azuma N, Takeishi Y, Minamino T, Kihara Y, ...
  • De JH, Florez A, Fernandez JL, Acin F. Treatment of ...
  • Decousus H, Quéré I, Presles E, Becker F, Barrellier M-T, ...
  • Del Conde I, Peña C. Buerger disease (thromboangiitis obliterans). Tech ...
  • Vijayakumar A, Tiwari R, Kumar Prabhuswamy V. Thromboangiitis obliterans (Buerger's ...
  • Quintero OL, Rojas-Villarraga A, Mantilla RD, Anaya J-M. Autoimmune diseases ...
  • Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke ...
  • Smolen JS, Youngchaiyud U, Weidinger P, Kojer M, Endler AT, ...
  • Hassoun Z, Lacrosse M, De Ronde T. Intestinal involvement in ...
  • Sasaki S, Sakuma M, Kunihara T, Yasuda K. Distribution of ...
  • Asouri M, Alinejad Rokni H, Sahraian MA, Fattahi S, Motamed ...
  • Kopan R, Ilagan MXG. The canonical Notch signaling pathway: unfolding ...
  • Shapouri-Moghaddam A, Mohammadi M, Rahimi HR, Esmaeili H, Mahmoudi M, ...
  • Dargon PT, Landry GJ. Buerger's disease. Ann Vasc Surg. 2012;26(6):871-80. ...
  • Malik S, Bruner GR, Williams-Weese C, Feo L, Scofield RH, ...
  • Ehteshamfar SM, Afshari JT, Modaghegh MS, Mahmoudi M, Kazemzadeh GH, ...
  • Fritzler MJ. The antinuclear antibody test: last or lasting gasp?. ...
  • Syed RH, Gilliam BE, Moore TL. Rheumatoid factors and anticyclic ...
  • Moore TL, Dalrymple AM. Laboratory Studies in Autoimmune Diseases. Mo ...
  • Harrison M. Erythrocyte sedimentation rate and C-reactive protein. Aust Prescr. ...
  • نمایش کامل مراجع